Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -55.79% | -30.00% | 7.94% | -24.36% | 375.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -55.79% | -30.00% | 7.94% | -24.36% | 375.00% |
| Cost of Revenue | -32.91% | -1.06% | 51.23% | -12.57% | 54.97% |
| Gross Profit | 17.27% | -20.18% | -78.79% | 3.09% | -6.11% |
| SG&A Expenses | -45.08% | 46.28% | -6.10% | 39.90% | 164.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.03% | 45.17% | 8.47% | 28.79% | 133.01% |
| Operating Income | 32.71% | -46.94% | -8.48% | -29.89% | -131.35% |
| Income Before Tax | 5.66% | -481.32% | 70.20% | 52.69% | 57.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.66% | -481.32% | 70.20% | 52.69% | 57.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.66% | -481.32% | 70.20% | 52.69% | 57.35% |
| EBIT | 32.71% | -46.94% | -8.48% | -29.89% | -131.35% |
| EBITDA | 32.94% | -46.75% | -8.25% | -29.91% | -131.77% |
| EPS Basic | -40.99% | -381.14% | 79.29% | 70.25% | 70.58% |
| Normalized Basic EPS | -8.08% | 7.05% | 84.61% | 16.46% | 39.68% |
| EPS Diluted | -41.55% | -398.88% | 79.29% | 70.27% | 70.34% |
| Normalized Diluted EPS | -8.08% | -2.04% | 84.61% | 16.46% | 39.68% |
| Average Basic Shares Outstanding | -12.69% | 92.05% | 93.63% | 93.63% | 84.93% |
| Average Diluted Shares Outstanding | -12.69% | 74.91% | 93.63% | 93.63% | 84.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |